Trial intelligence / Profile preview

FMT for MDRO Colonization in Solid Organ Transplant Recipients

NCT02816437Phase 1Withdrawn

Sponsor
University of Miami
Start
Jul 2016
Primary completion
Oct 2022
Modality
Live Biotherapeutic Products
01

Overview

Phase 1, open-label, single-arm trial of fecal microbiome transplant in organism colonization, sponsored by University of Miami. Primary endpoint: Number of participants with adverse events at 10 months. Planned start Jul 2016; status: withdrawn.

02

Drugs

fecal microbiome transplant
03

Conditions

organism colonization

Beyond the preview

Go deeper on NCT02816437.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02816437.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call